Home Your basket
• Focus on the BPPV: Semont...
   Price 12.50 €
• Distortion product otoaco...
   Price 10.50 €
• Laryngeal neuroendocrin c...
   Price 5.50 €
• Exophthalmos arising from...
   Price 10.50 €
• Management of cervical ce...
   Price 10.50 €
• Facial nerve outcome af...
   Price 12.50 €
• Otosclerosis among patien...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Rejuvenation of the eye: ...
   Price 10.50 €
• Hyperglycemia after intra...
   Price 8.50 €
• Total ossicular reconstru...
   Price 10.50 €
• Management of swallowing ...
   Price 8.50 €
• Sphenochoanal polyp: Repo...
   Price 5.50 €
• Endoscopic sphenoid proce...
   Price 8.50 €
• Diagnosis of submandibula...
   Price 10.50 €
• The Voice Handicap Index:...
   Price 10.50 €
• Treatment of severe epist...
   Price 5.50 €
• Saddle nose surgery: Long...
   Price 10.50 €
• Massive bone dystrophic l...
   Price 5.50 €
• Validation of a self-asse...
   Price 10.50 €
• Transsexuality: Speech th...
   Price 10.50 €
• Botulinum toxin and rejuv...
   Price 10.50 €
• Deafness in adults. Study...
   Price 10.50 €
• Treatment and rehabilitat...
   Price 10.50 €
• Defects in accuracy of th...
   Price 10.50 €
• Eye rings: Morphological ...
   Price 10.50 €
• Ethmoid-nasal meningioma ...
   Price 10.00 €
• Assessment of migraine re...
   Price 8.50 €
• Laryngeal papillomatosis ...
   Price 5.50 €
• A report of two cases of ...
   Price 5.50 €
• Diagnosis of non organic ...
   Price 8.50 €
• Benign paroxysmal positio...
   Price 5.50 €
• Art and nose....
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Communication disorders m...
   Price 5.50 €
• Frontal sinus osteoma com...
   Price 5.50 €
• Total pharyngolayngectomy...
   Price 10.50 €
• International Conference ...
   Price 5.50 €
• Oto-rhino-laryngology and...
   Price 10.50 €
• Occult otologic fistulas ...
   Price 5.50 €
• Salivary gland choristoma...
   Price 5.50 €
• "Sonorous man" - an appro...
   Price 8.50 €
• Middle ear osteoma: A rar...
   Price 8.50 €
• Surgical management of ma...
   Price 10.50 €
• Endoscopic resection of s...
   Price 10.50 €
• Cervical lymph node metas...
   Price 8.50 €
• Impaired laryngeal mobili...
   Price 10.50 €
• Pathophysiology, assessme...
   Price 12.50 €
• Treatment failures in ben...
   Price 10.50 €
• Human skull development a...
   Price 10.50 €
• Recovery of saccular func...
   Price 8.50 €
• Effect of vestibular neur...
   Price 10.50 €
• Functional anatomy of the...
   Price 14.00 €
• Prospective evaluation of...
   Price 10.50 €
• Reliability of CT-Scan in...
   Price 8.50 €
• Thyroid tuberculosis asso...
   Price 5.50 €
• Implementation of the Eur...
   Price 10.50 €
• Botulinum toxin, descript...
   Price 12.50 €
• Vocal effectiveness in sp...
   Price 10.50 €
• Temporary loss of visual ...
   Price 8.50 €
• The eye movement autophon...
   Price 14.00 €
• Cervicofacial cellulitise...
   Price 10.50 €
• Aesthetic profiloplasty: ...
   Price 10.50 €
• Guidelines for the clinic...
   Price 12.00 €
• Evaluation and treatment ...
   Price 8.50 €
• Anosmia following superio...
   Price 5.50 €
• Assessing efficacy of voi...
   Price 5.50 €
• The “Deglutition Handicap...
   Price 10.50 €
• Post operative Caldwell-L...
   Price 10.00 €

Total Order 629.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Download
o Issue N# 1 - 2000 o

OTONEUROLOGY

The natural history of untreated vestibular schwannomas. Is there a role for conservative management ?


Authors : R. M. Walsh, A. P. Bath, M. L. Bance, A. Keller, C. H. Tator, J. A. Rutka (Toronto)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,1:21-26.

Article published in english



Summary : Objective: the aim of this study was to investigate the natural history and outcome following the conservative management of a group of patients with unilateral vestibular schwannomas. Methods: 72 patients with a radiological diagnosis of unilateral vestibular schwannoma were managed conservatively because of poor general health, advanced age, patient preference, small tumour size, minimal symptoms, or tumour in the only / better hearing ear. All patients underwent serial magnetic resonance imaging for assessment of tumour growth, according to American Academy of Otolaryngology-Head & Neck Surgery guidelines (1995). The mean duration of follow-up was 37.8 months (range 12-194 months). Patients were deemed to have failed conservative management if there was evidence of continuous or rapid radiological tumour growth, and / or increasing symptoms or signs. Results : the mean tumour growth rate was 1.16 mm/year (range -0.75 to 9.65 mm/year). Approximately 83% of tumours grew at less than 2 mm/year. Significant tumour growth (total growth > 1 mm) was seen in 36.4%, no or insignificant growth (0 - 1 mm) in 50%, and negative growth (< 0 mm) in 13.6% of tumours. The growth rate of cerebellopontine angle (CPA) tumours (1.4 mm/year) was significantly greater than that of tumours limited to the internal auditory canal (IAC) (0.2 mm/year) (p = 0.001). Failure of conservative management, in which active treatment was required, occurred in 15.3%. The outcome of these patients appeared to be as favourable as those who underwent primary treatment, without a period of conservative management. The growth rate of tumours in patients who failed conservative management (4.2 mm/year) was significantly greater than that in patients who did not fail (0.5 mm/year) (p < 0.01). No factors predictive of tumour growth were identified. Deterioration of mean pure tone average (0.5, 1, 2, 3 kHz) and speech discrimination scores occurred regardless of whether radiological tumour growth was demonstrated or not. Conclusions: The majority of vestibular schwannomas are slow growing, although, CPA tumours appear to grow faster than IAC tumours. Deterioration of auditory function occurs even in the absence of tumour growth. Although most Otolaryngologists and Neurosurgeons would agree that the treatment of choice for the majority of vestibular schwannomas is microsurgery, there remains a small group of patients in whom a conservative management approach may be a desirable alternative.


|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE